Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H29N5O6 |
| Molecular Weight | 447.4849 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)CN1CCN(C[C@@H]2CN(C(=O)O2)C3=CC=C(C=C3)C(=N)NC(=O)OC)CC1
InChI
InChIKey=YNBHAPKHWDNTMZ-QGZVFWFLSA-N
InChI=1S/C21H29N5O6/c1-3-31-18(27)14-25-10-8-24(9-11-25)12-17-13-26(21(29)32-17)16-6-4-15(5-7-16)19(22)23-20(28)30-2/h4-7,17H,3,8-14H2,1-2H3,(H2,22,23,28)/t17-/m1/s1
| Molecular Formula | C21H29N5O6 |
| Molecular Weight | 447.4849 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Gantofiban (or EMD 122 347) is an oral double prodrug of the drug, EMD 132338 and is GPIIb/IIIa antagonist. The drug participated in phase II clinical trials in Japan in patients with thrombosis. However, in May 2004, Yamanouchi, the developing company, announced that the study was discontinued. Besides gantofiban was involved in phase II trials, like a treatment option in patients with the acute coronary syndrome. However, further information is not available.
Originator
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:25:51 GMT 2025
by
admin
on
Mon Mar 31 18:25:51 GMT 2025
|
| Record UNII |
MRG9KH7HF6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29750
Created by
admin on Mon Mar 31 18:25:51 GMT 2025 , Edited by admin on Mon Mar 31 18:25:51 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID70171433
Created by
admin on Mon Mar 31 18:25:51 GMT 2025 , Edited by admin on Mon Mar 31 18:25:51 GMT 2025
|
PRIMARY | |||
|
MRG9KH7HF6
Created by
admin on Mon Mar 31 18:25:51 GMT 2025 , Edited by admin on Mon Mar 31 18:25:51 GMT 2025
|
PRIMARY | |||
|
C73227
Created by
admin on Mon Mar 31 18:25:51 GMT 2025 , Edited by admin on Mon Mar 31 18:25:51 GMT 2025
|
PRIMARY | |||
|
9824864
Created by
admin on Mon Mar 31 18:25:51 GMT 2025 , Edited by admin on Mon Mar 31 18:25:51 GMT 2025
|
PRIMARY | |||
|
CHEMBL78871
Created by
admin on Mon Mar 31 18:25:51 GMT 2025 , Edited by admin on Mon Mar 31 18:25:51 GMT 2025
|
PRIMARY | |||
|
183547-57-1
Created by
admin on Mon Mar 31 18:25:51 GMT 2025 , Edited by admin on Mon Mar 31 18:25:51 GMT 2025
|
PRIMARY | |||
|
7836
Created by
admin on Mon Mar 31 18:25:51 GMT 2025 , Edited by admin on Mon Mar 31 18:25:51 GMT 2025
|
PRIMARY | |||
|
300000036886
Created by
admin on Mon Mar 31 18:25:51 GMT 2025 , Edited by admin on Mon Mar 31 18:25:51 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|